![Public Health Review Morning Edition artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts115/v4/66/23/d0/6623d0c0-1eef-ee5c-55a8-0f88dda85236/mza_441932648873605984.png/100x100bb.jpg)
174: Slow Uptake for COVID Therapies
Public Health Review Morning Edition
English - May 09, 2022 09:00 - 7 minutes - 9.8 MB - ★★★★★ - 44 ratingsMedicine Health & Fitness Government healthcare health healthnews news publichealth Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 173: Talking About Ticks
Next Episode: 175: Tracking Threats to Pregnancy Health
Dr. Manisha Juthani, Connecticut’s Public Health Commissioner, explains why providers may not be prescribing COVID-19 therapeutics; ASTHO publishes a new report to help public health leaders maximize the benefits of COVID-19 therapies; Latoya Sahadeo, ASTHO’s Director of Leadership Development, says the organization is accepting applications for the second class of scholars in the Diverse Executives Leading in Public Health program; and there’s still time to register for ASTHO’s Public Health TechXpo starting tomorrow online.
ASTHO Webpage: Diverse Executives Leading in Public Health
ASTHO Website: Public Health TechXpo
ASTHO TechXpo Sponsor: RTI International